Form 4: Plus Therapeutics CFO Reports Stock Transaction
Insider Transaction (Form 4)
Andrew John Hugh Macintyre Sims, Chief Financial Officer of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 1,533 Common Stock on October 1, 2026; holds 11,474 after (Direct).
- Option exercise/conversion: acquired 1,165 Common Stock on October 1, 2026; holds 12,639 after (Direct).
- Option exercise/conversion: acquired 287 Common Stock on October 1, 2026; holds 12,926 after (Direct).
- Option exercise/conversion: disposed of 1,533 Restricted Stock Units on October 1, 2026; holds 25,537 after (Direct).
- Option exercise/conversion: disposed of 1,165 Restricted Stock Units on October 1, 2026; holds 24,372 after (Direct).
- Option exercise/conversion: disposed of 287 Restricted Stock Units on October 1, 2026; holds 24,085 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew John Hugh Macintyre Sims — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,533 | — | — | 11,474 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,165 | — | — | 12,639 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 287 | — | — | 12,926 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,533 | — | — | 25,537 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,165 | — | — | 24,372 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 287 | — | — | 24,085 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (1,533 shares) |
| 2026-10-01 | Option exercise/conversion (1,165 shares) |
| 2026-10-01 | Option exercise/conversion (287 shares) |
| 2026-10-01 | Option exercise/conversion (1,533 shares) |
| 2026-10-01 | Option exercise/conversion (1,165 shares) |
| 2026-10-01 | Option exercise/conversion (287 shares) |
Keywords
insider transaction, Form 4, CNSY, CERENOME, INC., neutral, Andrew John Hugh Macintyre Sims
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.